Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective

Ultrasound (US) can reveal the presence of steatosis in non-alcoholic fatty liver disease (NAFLD), but its diagnostic accuracy to reveal signs of fibrosis is low except in advanced stages of disease (e.g. cirrhosis). Current guidelines suggest the use of clinical algorithms, such as the NAFLD fibros...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Immunopathol Pharmacol
Prif Awduron: Tana, Claudio, Schiavone, Cosima, Ticinesi, Andrea, Lauretani, Fulvio, Nouvenne, Antonio, Dietrich, Christoph Frank, Meschi, Tiziana
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2018
Pynciau:
Letter to the Editor
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992803/
https://ncbi.nlm.nih.gov/pubmed/29873275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2058738418781373
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg